Genentech
A topic on our watch list — we track its coverage across 2 domains, including Biotech Pharma and KRAS Research.
Coverage of Genentech is newly on the wire: 5 signals on the latest tracked day, level with its three-week baseline of 5, across 2 domains. That makes it the #333 most-covered of the 349 concerns we track.
If Genentech matters to your work, it just crossed our flagging thresholds — early and thin history, so watch whether the next few days confirm the move or fade it.
What’s changed
- IDEAYA Biosciences (IDYA) Is Up 5.2% After Genentech KRAS G12D Trial Collaboration News - Has The Bull Case Changed? - Sahm · KRAS Mutation Research (Google News) · 2026-08-21
- IDEAYA Biosciences Announces Clinical Collaboration with Genentech in MTAP-Deleted KRAS G12D-Mutant Pancreatic Cancer - PR Newswire · KRAS Mutation Research (Google News) · 2026-08-19
- Genentech doubles down on IDEAYA’s PRMT5 strategy with KRAS G12D combo - AllSci · KRAS Mutation Research (Google News) · 2026-08-19
- Single-cell mapping of the fallopian tube reveals a genomically unstable secretory cell state enriched in carriers of germline BRCA1/2 mutations · bioRxiv Cancer Biology · 2026-08-27
- BioNTech-Genentech cancer vax records more deaths than control in scrapped ph. 2 test · Fierce Biotech · 2026-08-28 · usually covers Pharma Pipeline
- Business Watch: DOE gives out money for batteries; Genentech licenses a GLP-1 alternative · Chemical & Engineering News · 2026-08-26 · usually covers Chemicals
What the reporting says
Across 27 tracked stories from 12 outlets, reporting on Genentech most often describes launches or releases (3), regulatory approvals (2), military action (1).
It shows up alongside Astrazeneca (8), Bristol Myers Squibb (8), Competing Interest Statement (8), KRAS (8), Abstract (8).
Two steps out: AI (through Abstract, 8 shared stories on the weaker link); Braf (through KRAS, 8 shared stories on the weaker link); Catalyzex Code Finder (through Abstract, 8 shared stories on the weaker link); China (through Astrazeneca, 8 shared stories on the weaker link).
Tracked since May 16, with coverage on 16 separate days — concentrated in Preprint and Kras Research.